Oculis Holding AG
F:CR5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oculis Holding AG
F:CR5
|
CH |
|
D
|
Dolby Laboratories Inc
F:FUO
|
US |
|
Alliance Entertainment Holding Corp
NASDAQ:AENT
|
US |
|
Eagle Bancorp Montana Inc
NASDAQ:EBMT
|
US |
|
Jensen-Group NV
F:XD1
|
BE |
|
R
|
Redcare Pharmacy NV
DUS:RDC
|
NL |
Wall St Price Targets
CR5 Price Targets Summary
Oculis Holding AG
According to Wall Street analysts, the average 1-year price target for CR5 is 29.14 EUR with a low forecast of 22.15 EUR and a high forecast of 41.21 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CR5's stock price target?
Price Target
29.14
EUR
According to Wall Street analysts, the average 1-year price target for CR5 is 29.14 EUR with a low forecast of 22.15 EUR and a high forecast of 41.21 EUR.